DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Human Microbiome Market - Global Forecast to 2025" report to their offering.
The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022-2025).
Factors such as increased focus on human microbiome therapy, growing demand for human microbiomes as new validated targets for drug development, and the need for early disease detection and diagnosis are expected to drive the growth of the human microbiome market.
Europe currently forms the largest human microbiome market in terms of demand for prebiotics and probiotics. The North American region is expected to register the highest growth rate due to its immense growth opportunities. Scientific evidence of health benefits of certain ingredients such as probiotics, prebiotics, etc. and the search for new opportunities to add value to the existing products are also expected to propel the global market growth. The demand for prebiotics and probiotics is increasing across various regions owing to the awareness among consumers regarding the favorable benefits of the microbiome community also referred as friendly bacteria. Most of the consumers prefer these products for maintaining good health and to use enhanced efficiency of ingredients, which offer products with bio-therapeutic properties. With the advancement in technology, the usage of probiotics is likely to extend beyond the current arena of gut, dental, and immune health to several other areas of human health.
Moreover, the rising incidence of cardiac diseases and other diseases such as diabetes and obesity are also expected to contribute to the growth of the human microbiome market. Increasing side effects and diminishing of human gut flora, due to excessive use of antibiotics, is likely to drive the growth of the human microbiome market. The application market is also expected to be a prominent segment owing to the use of microbiome as diagnostics and therapeutics.
- E.I. du Pont de Nemours and Company
- Enterome Bioscience
- Merck & Co., Inc.
- Metabiomics Corporation
- Microbiome Therapeutics, LLC
- OSEL, Inc.
- Second Genome, Inc.
- Vedanta Biosciences, Inc.
- Vithera Pharmaceuticals
Yakult Honsha Co., Ltd.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Human Microbiome Market, By Product
7 Human Microbiome Market, By Application
8 Human Microbiome Market, By Disease
9 Human Microbiome Research Spending Market, By Product
10 Human Microbiome Research Spending Market, By Technology
11 Human Microbiome Market, By Region
12 Competitive Landscape
13 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/zwhbcv/human_microbiome